1. Home
  2. MRCY vs BLLN Comparison

MRCY vs BLLN Comparison

Compare MRCY & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

HOLD

Current Price

$98.92

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$133.48

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRCY
BLLN
Founded
1981
2016
Country
United States
United States
Employees
N/A
713
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.8B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
MRCY
BLLN
Price
$98.92
$133.48
Analyst Decision
Buy
Buy
Analyst Count
8
7
Target Price
$80.00
$126.71
AVG Volume (30 Days)
620.6K
588.5K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
72.69
N/A
EPS
N/A
N/A
Revenue
$912,020,000.00
N/A
Revenue This Year
$6.59
$46.29
Revenue Next Year
$9.56
$30.14
P/E Ratio
N/A
N/A
Revenue Growth
9.19
N/A
52 Week Low
$50.13
$61.96
52 Week High
$128.45
$138.70

Technical Indicators

Market Signals
Indicator
MRCY
BLLN
Relative Strength Index (RSI) 43.70 63.49
Support Level $70.51 $79.07
Resistance Level $103.81 $138.70
Average True Range (ATR) 5.63 7.32
MACD -0.46 -0.64
Stochastic Oscillator 28.34 97.01

Price Performance

Historical Comparison
MRCY
BLLN

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: